Works matching IS 1386341X AND DT 2015 AND VI 18 AND IP 3


Results: 20
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study.

    Published in:
    Pituitary, 2015, v. 18, n. 3, p. 385, doi. 10.1007/s11102-014-0585-6
    By:
    • Sheppard, Michael;
    • Bronstein, Marcello;
    • Freda, Pamela;
    • Serri, Omar;
    • Marinis, Laura;
    • Naves, Luciana;
    • Rozhinskaya, Liudmila;
    • Hermosillo Reséndiz, Karina;
    • Ruffin, Matthieu;
    • Chen, YinMiao;
    • Colao, Annamaria
    Publication type:
    Article
    15
    16
    17
    18
    19

    Evaluation of survivin splice variants in pituitary tumors.

    Published in:
    Pituitary, 2015, v. 18, n. 3, p. 410, doi. 10.1007/s11102-014-0590-9
    By:
    • Waligórska-Stachura, Joanna;
    • Andrusiewicz, Mirosław;
    • Sawicka-Gutaj, Nadia;
    • Kubiczak, Marta;
    • Jankowska, Anna;
    • Liebert, Włodzimierz;
    • Czarnywojtek, Agata;
    • Waśko, Ryszard;
    • Blanco-Gangoo, Al;
    • Ruchała, Marek
    Publication type:
    Article
    20